These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 33289345

  • 1. Massive submacular haemorrhage in polypoidal choroidal vasculopathy versus typical neovascular age-related macular degeneration.
    Cho SC, Cho J, Park KH, Woo SJ.
    Acta Ophthalmol; 2021 Aug; 99(5):e706-e714. PubMed ID: 33289345
    [Abstract] [Full Text] [Related]

  • 2. Influence of submacular hemorrhage at baseline on the long-term outcomes of aflibercept treatment for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
    Hosokawa MM, Ouchi C, Shiode Y, Kimura S, Matoba R, Morita T, Morizane Y.
    Graefes Arch Clin Exp Ophthalmol; 2024 Oct; 262(10):3099-3107. PubMed ID: 38625447
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy.
    Baek J, Lee JH, Jung BJ, Kook L, Lee WK.
    Graefes Arch Clin Exp Ophthalmol; 2018 Dec; 256(12):2309-2317. PubMed ID: 30259090
    [Abstract] [Full Text] [Related]

  • 7. Comparison of choriocapillary flow density between fellow eyes of polypoidal choroidal vasculopathy and neovascular age-related macular degeneration.
    Luo M, Zhao X, Zhao N, Yuan M, Yang J, Dai R, Chen Y.
    BMC Ophthalmol; 2020 Apr 22; 20(1):162. PubMed ID: 32321472
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fundus autofluorescence in polypoidal choroidal vasculopathy.
    Yamagishi T, Koizumi H, Yamazaki T, Kinoshita S.
    Ophthalmology; 2012 Aug 22; 119(8):1650-7. PubMed ID: 22512987
    [Abstract] [Full Text] [Related]

  • 14. Outcomes of vitrectomy combined with subretinal tissue plasminogen activator injection for submacular hemorrhage associated with polypoidal choroidal vasculopathy.
    Kimura S, Morizane Y, Hosokawa MM, Shiode Y, Doi S, Hosogi M, Fujiwara A, Okanouchi T, Inoue Y, Shiraga F.
    Jpn J Ophthalmol; 2019 Sep 22; 63(5):382-388. PubMed ID: 31243593
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Submacular hemorrhage and grape-like polyp clusters: factors associated with reactivation of the lesion in polypoidal choroidal vasculopathy.
    Kim JH, Chang YS, Kim JW, Kim CG, Lee DW.
    Eye (Lond); 2017 Dec 22; 31(12):1678-1684. PubMed ID: 28707675
    [Abstract] [Full Text] [Related]

  • 20. Prognostic factors after aflibercept therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy.
    Ogasawara M, Koizumi H, Yamamoto A, Itagaki K, Saito M, Maruko I, Okada AA, Iida T, Sekiryu T.
    Jpn J Ophthalmol; 2018 Sep 22; 62(5):584-591. PubMed ID: 29974277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.